These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of large intermittent intravenous doses of cyclophosphamide in lymphoma. Mendelson D; Block JB; Serpick AA Cancer; 1970 Mar; 25(3):715-20. PubMed ID: 4906723 [No Abstract] [Full Text] [Related]
5. [Anaphylactic shock in cyclophosphamide infusion]. Aulbert E; Kurschel E; Reichenberger M; Schmidt CG Med Welt; 1982 Dec; 33(51-52):1845-7. PubMed ID: 7162403 [No Abstract] [Full Text] [Related]
6. Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin's disease and the lymphomas. Jacobs EM; Peters FC; Luce JK; Zippin C; Wood DA JAMA; 1968 Feb; 203(6):392-8. PubMed ID: 4865234 [No Abstract] [Full Text] [Related]
7. Primary lymphoma of the bladder: case report. Riccioni R; Carulli G; de Maria M; Pacini S; Cagno C; Selli C; Petrini M Am J Hematol; 2006 Jan; 81(1):77-8. PubMed ID: 16369978 [No Abstract] [Full Text] [Related]
8. Late-onset anaphylactic reactions following i.v. cyclophosphamide pulse in a patient with systemic sclerosis and systemic lupus erythematosus overlap syndrome. Taniguchi T; Asano Y; Tamaki Z; Takahashi T; Ichimura Y; Toyama T; Kagami S; Mitsui H; Sato S J Dermatol; 2014 Oct; 41(10):912-4. PubMed ID: 25227247 [TBL] [Abstract][Full Text] [Related]
9. Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Carbone PP; Spurr C; Schneiderman M; Scotto J; Holland JF; Shnider B Cancer Res; 1968 May; 28(5):811-22. PubMed ID: 4870882 [No Abstract] [Full Text] [Related]
11. Immediate hypersensitivity reaction to cyclophosphamide. Knysak DJ; McLean JA; Solomon WR; Fox DA; McCune WJ Arthritis Rheum; 1994 Jul; 37(7):1101-4. PubMed ID: 8024619 [TBL] [Abstract][Full Text] [Related]
12. Anaphylactoid reaction with bronchospasm following intravenous cyclophosphamide administration. Salles G; Vial T; Archimbaud E Ann Hematol; 1991; 62(2-3):74-5. PubMed ID: 2031970 [TBL] [Abstract][Full Text] [Related]
13. [Primary non-Hodgkin lymphoma of the sternum]. Kabiri el H; Kabiri M; Doghmi K Arch Bronconeumol; 2009 May; 45(5):259-60. PubMed ID: 19376627 [No Abstract] [Full Text] [Related]
14. Anaphylactoid reaction to cyclophosphamide in a patient with T cell lymphoma and hemophagocytic syndrome. Minami R; Hirase N; Motomura S; Muta K; Nawata H; Nishimura J Int J Hematol; 1999 Jan; 69(1):57-8. PubMed ID: 10641445 [No Abstract] [Full Text] [Related]
15. Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. Johnson WW; Meadows DC N Engl J Med; 1971 Feb; 284(6):290-4. PubMed ID: 4321778 [No Abstract] [Full Text] [Related]
16. [The use of high-dose cyclophosphamide in the treatment of human solid tumors]. Meeus-Bith L; Clavel B; Gazeau JN; Bourdin JS Sem Hop; 1968 Dec; 44(53):3307-20. PubMed ID: 4307497 [No Abstract] [Full Text] [Related]
17. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Decker M; Rothermundt C; Holländer G; Tichelli A; Rochlitz C Lancet Oncol; 2006 Aug; 7(8):693-4. PubMed ID: 16887487 [No Abstract] [Full Text] [Related]
18. [Malignant non-Hodgkin diffuse lymphoma with extranodal orbital involvement--a clinical case]. Epure C; Ionascu L; Hagima N; Nan S; Stefaniu I Oftalmologia; 2005; 49(4):29-32. PubMed ID: 16524121 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of cyclophosphamide in the management of reticulum cell sarcoma. Hyman GA; Cassileth PA Cancer; 1966 Oct; 19(10):1386-92. PubMed ID: 5337272 [No Abstract] [Full Text] [Related]
20. Possible anaphylactic reaction to cyclophosphamide. Lakin JD JAMA; 1977 Apr; 237(17):1827. PubMed ID: 576688 [No Abstract] [Full Text] [Related] [Next] [New Search]